Shareholders in IonQ (NYSE: IONQ) are currently paying 24.0 times trailing revenue for a company whose operations lost $1,270 million over the past twelve months.
That valuation stands against a broader market trading at just 3.1 times sales, underscoring how much future promise is already embedded in the stock price.
The steep premium has done nothing to prevent a brutal slide, with IONQ shares down 50.9% over the past year while the S&P 500 gained 11.0%.
Yet the underlying business tells a different story, one that complicates any straightforward decision to cut losses and exit.
On November 5, 2026, management delivered what it described as a sixth consecutive record revenue quarter, a run of momentum that few unprofitable technology companies can claim.
Third-quarter revenue hit $174 million, a 336% jump from the same period a year earlier, though part of that surge reflects two months of contribution from SkyWater, the chip foundry IonQ acquired at the end of July.
Even stripping out the foundry, the IonQ Platform segment generated $90.3 million in the quarter, representing 127% growth, suggesting the core quantum computing business is accelerating on its own terms.
Management responded to the strong quarter by lifting its full-year 2026 revenue forecast to between $505 million and $515 million, up from a prior range of $450 million to $460 million.
On the demand side, the company said all of its 2027 capacity for the Superion 256 quantum computers has already been sold, and remaining performance obligations closed the quarter at $1.2 billion in contracted but undelivered work.
The profitability picture is harder to defend, with operating losses running at 333.9% of revenue over the trailing twelve months, compared with an 18.9% operating margin for the average S&P 500 constituent.
A reported net income figure of $255 million for the past twelve months obscures that reality, since the Q3 profit of $564 million was driven largely by an $896 million non-cash gain tied to a change in the fair value of the company’s warrants.
Free cash flow over the same period reached -$689 million, a figure that would be existential for most companies but is cushioned by a significant capital raise.
IonQ pulled in $2 billion during October, lifting its pro forma cash position to $3.7 billion, buying the company considerable runway to pursue a path toward profitability.
To advance that effort, management has appointed a new chief financial officer, set to take the role in early December, a signal that financial discipline is becoming a priority alongside growth.
Revenue has expanded at a three-year average annual rate of 193.1%, dwarfing the S&P 500’s 6.5% pace, but that trajectory originated from a small base and will face tougher comparisons ahead.
Investors will get their next clear read on the business when IonQ is expected to report fourth-quarter results in February 2027, which will reveal whether full-year revenue landed inside the raised guidance range.
At current prices, selling crystallizes a loss of roughly half the invested capital on a business whose sales are still climbing sharply and whose order book is already filling future years.
The central tension for holders is that 24.0 times sales is a multiple that demands continued hypergrowth, a standard that even strong recent performance may struggle to justify indefinitely.